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Abstract
Objective To examine attitudes towards drug use
among middle aged respondents with high levels of
chronic morbidity.
Design Qualitative study with detailed interviews.
Setting West of Scotland.
Participants 23 men and women aged about 50 years
with four or more chronic illnesses.
Main outcome measure Participants’ feelings about
long term use of drugs to manage chronic multiple
morbidity.
Results Drugs occupied a central place in the way
people managed their comorbidities. Respondents
expressed an aversion to taking drugs, despite
acknowledging that they depended on drugs to live as
“normal” a life as possible. Respondents expressed
ambivalence to their drugs in various ways. Firstly, they
adopted both regular and more flexible regimens and
might adhere to a regular regimen in treating one
condition (such as hypertension) while adopting a
flexible regimen in relation to others, in response to
their experience of symptoms or varying demands of
their daily life. Secondly, they expressed reluctance to
take drugs, but an inability to be free of them. Thirdly,
drugs both facilitated performance of social roles and
served as evidence of an inability to perform such roles.
Conclusions Insight into the considerable tension
experienced by people managing complex drug
regimens to manage multiple chronic illness may help
medical carers to support self care practices among
patients and to optimise concordance in their use of
prescribed drugs.
Introduction
About half of the drugs prescribed for patients with
long term conditions are not taken as prescribed.1 This
non-adherence has been described as a “serious deficit
at the core of medical practice, with consequent
massive personal, societal, and economic cost.”2
Haynes et al emphasise the need for a better
understanding of non-adherence and note that, “With
the astonishing advances in medical therapeutics
during the past two decades, one would think that
studies on the nature of non-adherence . . . would
flourish.”1 But few studies of users’ views of drugs have
been published, especially when compared with the
extensive literature on lay beliefs about illness.3 Studies
of patients’ ideas about prescribed drugs have focused
on people with specific conditions,4–8 or on samples
recruited through general practice.3 9–12
What is missing is the perspective of people with
long term multiple morbidity. This is an important
omission given that such patients receive a battery of
different drugs to manage their conditions, account for
a substantial amount of health service use, and can
present general practitioners with particular problems
in the management of comorbidity.13 We address this
gap by reporting on attitudes to drug use among mid-
dle aged patients with multiple chronic conditions.
Participants and methods
This research formed part of a wider study on the
experience and management of illness among people
with multiple morbidity, which focused specifically on
why some frequently consulted primary care services
whereas others did not. Our study sample comprised
respondents purposively selected from the west of
Scotland twenty-07 study.14 15 This is an ongoing longi-
tudinal study of the social patterning of health among
men and women resident in a large, socially varied (but
mainly urban) area centred on Glasgow. Respondents
have completed lengthy, home based interviews
conducted by nurses at roughly five-yearly intervals
since 1987-8. These included detailed descriptions of
chronic conditions, collected with an extended version
of the question on longstanding illness16 that is
included annually in the British general household
survey.17 Respondents were also asked about the
number of surgery consultations with their general
practitioner, on their own behalf, in the year before the
interview.
Analysis of data collected in 1995-6 showed that,
although reported morbidity and symptoms
accounted for about a third of the variation in general
practitioner consultations, much remained unex-
plained even after taking account of other factors.18 19
In order to explore this further we conducted a quali-
tative study with people (born in the early 1950s) who
reported high morbidity (four or more chronic condi-
tions) in the interviews in 2000-2, half of whom were
“low consulters” ( ≤ 3 consultations in previous year)
and half were “high consulters” ( ≥ 7 consultations).
This study presents all respondents’ attitudes to drugs;
differences between high and low consulters are
addressed elsewhere.
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Data collection
We sent letters to 41 respondents who fulfilled our
morbidity and consultation criteria asking if they
would be willing to take part in this additional qualita-
tive study. We explained that this would involve two
interviews, about three weeks apart, and the comple-
tion of a symptom diary for two weeks between the
interviews. Twenty three people (13 women, 10 men)
participated, 20 of whom took part in two interviews.
AT conducted the interviews (each lasting about an
hour) between October 2001 and July 2002. At the
start of the interview, participants were asked to review
the information sheet that had been sent with the invi-
tation letter and to sign a consent form, which required
them to confirm that they agreed to be interviewed,
agreed to the interview being tape-recorded, and gave
permission for extracts of their interview to be used in
research publications and reports, with strict preserva-
tion of anonymity.
Of the 43 interviews, 40 took place in participants’
homes. Interviews were semi-structured, but partici-
pants were encouraged to talk freely about their expe-
riences and management strategies for their condi-
tions. The first interview consisted of three overlapping
sections—conditions and symptoms, the impact of con-
ditions on daily life (including any action taken), and
the use of formal services. The second interview
allowed greater focus on management of symptoms
(which had been recorded on a daily basis in a
symptom diary for 15 of the respondents).
Data analysis
The recorded interviews were transcribed in full, and
the analysis was based on the transcripts. We used a
constant comparative method for our analysis,20
facilitated by the use of the software package nVivo.
The data gathered from the interviews were wide rang-
ing; here we focus only on how respondents spoke
about their use of drugs, a major theme that emerged.
We analysed the transcripts in stages: AT checked
the transcripts for accuracy against tape-recordings
and made preliminary identification of themes; all
authors read the transcripts separately to identify
major themes; AT revised themes and the coding
scheme after discussion and repeated reading of tran-
scripts; we generated codes to label passages and
applied these to transcripts; and we explored themes
within and between respondents. Some themes related
to drug use (such as people’s aversion to drug use)
were immediately obvious and were coded from an
early stage of the analysis. Others (such as the higher
order theme of “ambivalence”) only emerged with fur-
ther analysis. Once such a theme had emerged explic-
itly from some interviews, we re-analysed the data to
establish whether others referred to the theme explic-
itly or implicitly and to look for deviant cases to
develop and refine the findings.
Results
Participants drew on a range of resources to manage
their chronic ill health. However, drugs occupied a
central place in all their lives, and, as all participants
had multiple chronic conditions, most drug regimens
were complex and sometimes demanding and restrict-
ing. For some participants, a complex drug regimen
was the only means through which they could gain
equilibrium, relief from distressing symptoms, or a
sense of having a “normal” life (though this varied in
degree of success and setbacks) (see box 1). Although
drug use seemed to have little impact on the lives of a
few respondents, most accounts revealed several
tensions and ambivalence in relation to drug use.
“Regular” regimen v “flexible” regimen
One tension was between the use of drugs taken
routinely at regular intervals in a drill-like way (as some
respondents described their use of antihypertensive
drugs) and a more flexible regimen that accommo-
dated changing circumstances. Failure to keep to a set
routine was often perceived to pose risks to the
successful eradication,management, or containment of
current symptoms or undesired future outcomes.
However, almost all respondents were taking several
different drugs, and they often referred to complex
strategies that they had adopted so that they could
remember to take the various drugs at the prescribed
times. Only one respondent (with schizophrenia,
depression, a peptic ulcer, diabetes, hiatus hernia, and
hypertension) spoke unproblematically of his com-
bined drug regimen (saying “keep[ing] taking the tab-
lets” was the most important part of the management
of his illnesses).
For most respondents, the experience of multiple
morbidity was characterised by fluctuating symptoms,
fear, uncertainty, and lack of control. In the face of
uncertainties about the exact manifestation of their
morbidity at a given time, the management of
medication was a reflexive activity based on constant
Box 1: Example of complex drug regimen to
facilitate “normal” life
“I’ve been trying to teach classes, and, you’ll speak and
at the same time think to myself, ‘God, this is bloody
sore,’ you know, ‘This is annoying.’ You were wishing it
was an hour later so I could take some more medicine.
You were sort of, you were interfering with the sort of
regime of the medicine too much, you know because if
you take it earlier it’s going to be earlier before you
take it again. . . .
“I can vary the dosage . . . like during the summer
holiday, I take a low dose morning, lunchtime, and a
big dose at night, you know. But some days I’ll maybe
vary that and will maybe take slightly more in the
morning when I’m not really good because I know
that I’m not going to work and so on. But I still try to
keep to the same daily dosage. You know, if I add
something on here I try and take it off there. . . . But it’s
quite difficult, though, especially if you’re trying to
lead, if you’re trying to be as normal as possible at the
same time, you know, that’s very difficult.
“So, for example, I couldn’t go back to work and be
like that. You know I couldn’t do a job like that. And
trying to come down from, say, six tablets to four
tablets a day, I couldn’t do that . . . I cut myself right
down before I went back to work because I knew that,
the dosage I was on, I wouldn’t be able to do the
job. . . . I just had to get it down. So about two to three
weeks before going back to work, I just got it down to
three and a half tablets a day, and it was hell for six
months, you know, the pain.”—Respondent 16, with a
pelvic abscess, asthma, eczema, and having had an
ileostomy and proctolectomy
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self assessment and monitoring. This sometimes led
respondents to vary their use of drugs to gain
maximum symptom control, or to seek further consul-
tations with their general practitioner to request new
drugs or higher doses of existing drugs.
“Flexible” use of painkillers was common (see box 1)
and the subject of lengthy descriptions of variations in
intensity of pain and drug use, although drugs for many
conditions (such as colitis, emphysema, anxiety) were
also described in this way (see box 2). Variations to
“fixed” regimens included supplementation by increas-
ing dose, introducing new drugs, or juggling timing.
Respondents might adhere to a regular regimen in
treating one condition (such as hypertension) while
adopting a flexible regimen for others (see box 2),
depending on their experience of symptoms in relation
to the demands of their daily life. The process at its sim-
plest was described by one respondent as “As required”
(respondent 2), although this phrase masks the
intricacies involved in self regulation.Descriptions of use
of painkillers emphasised a struggle between wanting to
take as few drugs as possible and adequate pain relief.
Reluctance to take drugs v the inability to be “free”
of drugs
All respondents expressed their dislike of drugs to
some extent, and drug use was often portrayed as the
“last resort.” This description served to emphasise a
degree of stoicism in their response to symptoms and
typically their struggle to make “responsible” (minimal)
use of drugs and (maximum) use of other management
strategies (such as going to bed, avoiding certain activi-
ties) to restrict the amount of medication needed.
People also spoke of not wanting to put “pills and
potions” (respondent 8) into their bodies; of fears of
dependency, side effects, or interactions with other
drugs; and of being wary of a prescription as a substi-
tute for a real “cure” or better strategy for managing
their underlying conditions.
However, respondents also talked of their need for
drugs, commonly for pain control and sometimes
explicitly for “survival” (see respondent 6 in box 3, who
was reluctant to take antidepressants but who
expressed a different view in relation to other drugs).
But respondents’ accounts often focused not only on
the alleviation of bodily sensations but on the desire to
have a life aside from their experience of illness, to
function “half normally” or to fulfil social roles or obli-
gations (see box 3). The image used by respondent 21
in box 3, of her husband “begging” her to take pain
killers and her three small daughters coming in from
school to see their mother still in bed, captures some of
the emotions involved in people’s response to drug
use. This sense, that drugs were turned to only in
extremis, was commonly voiced.
Drugs as facilitators of ability to perform social
roles v drugs as evidence of inability to perform
social roles
In some cases the main reason given for use and self
regulation of drugs was to control symptoms in order
to facilitate particular tasks or social roles and
obligations (see examples in box 3). Undertaking
activities to fulfil important social roles (as grandpar-
ents, parents, employees, etc) often aggravated distress-
ing symptoms, but this was justified by respondents
Box 2: Example of complex drug regimen
varied in response to symptoms
“My asthma’s normally bad if I take a chest infection.
So I up my inhalers and I up, I get put onto steroids to
help that. If my colitis is bad I take the normal colitis
tablets, plus I get put on steroids to stop if there is any
blood or anything and Prepos [suppository] that you
put inside you. So I take that as well. That’s not all
together. I mean, if my colitis is fine then I don’t take
anything, and if my asthma I just take, if its fine I just
take my inhalers. I’ve got to take the blood pressure
tablets, the ulcer tablets, and the inhalers every day,
and the water tablets.”—Respondent 10, with
hypertension, asthma, colitis, duodenal ulcer, thyroid
problems, and anxiety and depression
Box 3: Different presentations of “need” for drugs
For “survival”
“I’ve got 13 tablets I take in the morning, I take four at lunch time and five
going to bed. It’s a lot of tablets to be taking in a day.. . . Who wants to be on
medication for the rest of your life? I certainly don’t, but I know I’ve got to
because of the strokes and the high blood pressure. I have to, I know I have to,
take medication; I couldn’t survive without it.”—Respondent 6, with asthma,
hypertension, diabetes, osteoporosis, blood clots, anxiety, and depression
To function “normally”
It’s [taking a range of tablets for different conditions] routine, but I tend to
the ones like the dihydrocodeine. I mark down on a diary when I am taking
them so that I wouldn’t go over the eight in a day. Because when I am really
bad, if I didn’t, I’ve got so much pain that I can forget when I’ve taken it. . . .
I would love to be able to turn round and come off all these things, but to
be able to function half normally I’ve got to take them, and if that’s the way
it’s got to be, that’s the way it’s got to be.”—Respondent 8, with depression,
irritable bowel syndrome, sinus problems, sciatica, ovarian cysts, migraine,
and tinnitus
To fulfil tasks, social roles, or obligations
“I have to be up early in the morning to make sure I am alright for work [as
a teacher]; I’ll get up at six o’clock and I don’t leave till eight. So I get up at
six and just make sure I’m alright. I have Imodium to take . . . I have to take
Imodium, and that lets me get to work.”—Respondent 17, with irritable
bowel syndrome, migraine, hypertension, and inner ear problems
“I couldn’t bear watching my three young children coming in every day and
seeing me in bed. I had to do something, I knew I had to do something, and
I was very loath to take these antidepressants. I only took them because I
began to feel almost suicidal. At one point, my husband begged me to take
them . . . I couldn’t bear [the children] coming in from school and seeing me
still there unable to function really.”—Respondent 21, with myalgic
encephalitis, cyst on thyroid gland, palpitations, and allergy to dust
“Sometimes I do things I know I’m going to suffer for. But it can be a
difference of, maybe, sticking a set of brake pads on my car that takes me
half an hour, so maybe it’ll cost me £12 to do it myself. If I’d have not done
it, £60, so there’s times when I say, ‘I’d better just take a couple of pain killers
and do it,’ you know. Because they tell you you’re no supposed to live like a,
you know, do. At one time it was ‘Lie in a bed for two, three weeks,’ now
they’re telling you ‘Just do what you want, to work as normally.’”—
Respondent 15, with back pain, joint pain, photosensitivity, stomach
problems, and hay fever
“I cannae, to this day, go anywhere without them [antidepressants] being in
ma bag. . . . I cannae go the length of myself without them, but I can go
without taking them. As long as I know I’ve got them I’m fine, but I went to
the bingo one night and went into ma bag for somehin, and I thought, ‘Oh
God, I’ve nae tablets,’ and I widnae open the zip of ma bag . . . if I had
opened that and seen there were nae tablets I would’ve freaked, I would’ve
really. I would’ve went mad. Because if I’m gaun oot, I’m gaun to the shops
this afternoon, I’ll say, ‘I take three things with me: my purse, my Valium,
and my phone.’ As long as I’ve got them I’m happy.”—Respondent 23, with
breast cancer, anxiety, depression, panic attacks, and a gastric ulcer
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through their need to be “good” workers, parents, or
partners. Drugs thus played a part both in suppressing
symptoms to allow people to perform social roles cen-
tral to their self identity and in alleviating symptoms
aggravated by people doing more than they “should”
in performing these roles. In some cases this led to a
lengthy discussion of the moral dilemmas and
ambiguities presented. This moral dimension to how
drugs “should” be used could be reinforced by others’
reactions: respondent 15, for example, remarked that
“Other people are always on to you—‘Oh you’re taking
too many of these pain killers, blah, blah, blah’—but
they’ve no’ got the back I’ve got.”
However, drugs could also represent ill health and
act as an indicator of dysfunction (see box 4). This
sometimes had the virtue of being one way of articulat-
ing to others, and affirming to oneself, the severity and
progress of chronic illnesses, thus diminishing the
sense of “difference” and isolation consequent on hav-
ing a high burden of morbidity at a relatively young
age. However, drug use could equally represent a
threat to identity. Thus drugs could both be seen to
restore previous identities threatened by chronic
illness and to be the concrete representation of the
threat to, or loss of, that identity.
Discussion
Several tensions emerged from the accounts of drug
use in these chronically ill people. Drug use was central
to their management of their multiple symptoms and
disabilities, and self regulation to gain maximum
symptom control was common.5 7 In common with
participants in other studies,3 5–9 our respondents also
showed an aversion to taking drugs, despite their
acknowledgment that they depended on drugs to live
as normal a life as possible. Respondents referred to
trying not to take drugs, resourcefulness in stopping or
minimising drug use, and sometimes a preference for
other strategies (such as counselling) over medication.
Drug use was discussed in moral terms to show how
individuals remained competent though seriously
challenged by their illnesses, were stoical in their
response to illness, and were responsible in their roles
as paid employees and family members. This raises the
question why such chronically ill patients with multiple
morbidity, who are much sicker and more restricted
than others of their age, feel the need to justify their
use of drugs in their accounts of managing their ill
health.
Two factors could contribute to this. Firstly, these
people are likely to need a complex array of drugs over
a long period to control their chronic conditions.
Rejection of short term use of drugs is not possible for
them. However, research has shown a widespread cul-
tural belief that drugs should be as little used as
possible.3–7 9 For example, in a sample of 544 people
drawn from four general practices, 86% agreed with
the statement “I would prefer not to take any medicine
if I can avoid it,” and 58% agreed with “I always take as
small a dose as possible.” Conversely, only 24% agreed
with the statement “I would be happy to take a
medicine over a long period of time,” 26% agreed with
“If I’m feeling ill I like to take medicine,” and 15%
agreed with “When you are ill you should always take a
medicine.”12 Against this background, people who
already may feel isolated or conspicuous because of
their poor health may not wish to exaggerate this by
rejecting common shared beliefs about drug taking.
Secondly, these people are relatively young to have
such high levels of morbidity. They are likely to be con-
scious that they are more incapacitated and larger con-
sumers of healthcare resources (in terms of drug use,
general practitioners’ time, etc) than their contempo-
raries. In their late 40s and early 50s, they have had to
come to terms with the restrictions that their chronic
illnesses impose at an age when they would be
expected to be at the peak of their wage earning
potential with responsibility for supporting children
and ageing parents. In this context it is unsurprising
that they take such trouble to show that they are
“really” ill and frustrated in their inability to live normal
lives, to show their moral integrity in the face of
What is already known on this topic
There is widespread aversion to taking drugs and
considerable non-adherence to prescribed drug
regimens
Little is known about the experience of drug
taking in people with chronic multiple morbidity
What this study adds
People with multiple morbidity expressed
ambivalence to taking drugs in several ways: one
tension was between the use of a regular drug
regimen and a more flexible regimen as people
self regulated their drug use in an attempt to gain
equilibrium, relief from symptoms, or sense of a
“normal” life
Further ambivalence was shown in people
expressing reluctance to take drugs and their
inability to be “free” of them; also that drugs both
enabled respondents to continue to function in
social roles and acted as marker for their inability
to perform such roles
Drug use was discussed in moral terms to show
how people remained competent though seriously
challenged by their illnesses, were stoical in their
response to illness, and were responsible in their
roles as employees and family members
Box 4: Example of drug use to signify extent of
ill health
Interviewer: “Can you tell me in as much detail as you
can, in your own words, what conditions you have?”
“I take medication for high blood pressure, which is
due to a, what I was told at the [hospital] was that it’s a
non-specific kidney disorder. Also water tablet to help
control the blood pressure as well, aspirin, and I take
pain relief for my back and my leg, which I injured in
work two years ago. Well, more than two years ago
now. That’s basically all the medication I’m on
now.”—Respondent 2, with disc injury, kidney
problems, depression, arthritis, hypertension, and
penicillin allergy
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challenges to their ideal or former identities. Their
complex drug regimens mean that keeping their drug
use private21 is seldom possible, and thus it remains an
intrusive and constant indicator of their poor health.
Conclusions
The failure by patients to follow prescription advice is
well recognised, as are the related health and financial
costs. Part of the solution to the mismatch between
prescribing and consuming drugs lies in trying to
understand people’s experience and use of drugs. A
more reciprocal relationship between doctor and
patient could facilitate concordance.22 With increasing
emphasis on the patient as expert,23 a genuine shared
decision making process between patient and medical
carers seems appropriate. This can only be achieved if
the complexities and ambiguities involved in drug use
for those with multiple chronic illnesses are appreci-
ated by both parties.
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Commentary: Does a prescribed treatment match a
patient’s priorities?
Nicky Britten
Within the past 10 years several studies carried out in
different settings have investigated patients’ perceptions
of prescribed drugs. Most of these studies have been
qualitative and relatively small scale. They have all
revealed considerable ambivalence about drug taking.
This study by Townsend and colleagues confirms the
validity of these findings for a community based sample
of middle aged people in Scotland with multiple
morbidities and provides a rich description of the differ-
ent aspects of this ambivalence. Most prescribed drugs
are taken by elderly people with chronic conditions.
This study also helps to explain quantitative
research that has identified core beliefs about the per-
ceived necessity of taking prescribed drugs as well as
concerns about potential harms.1 It shows the futility of
labelling patients as “compliers” or “non-compliers,” as
the same person may take one drug regularly while
altering the dose or frequency of another. The paper
shows the ambiguous yet powerful impact of drug tak-
ing on people’s identity and the efforts that people
make to fulfil their family and social obligations. Above
all, the paper reveals the centrality of the notion of self
regulation of prescribed drugs, in which patients
organise their drug taking around their own priorities.
Patients’ priorities may therefore be very different
from prescribers’ priorities, or indeed from the priorities
that prescribers assume their patients to have. This
paper shows clearly that patients’ moral concerns and
the demands of their social roles are often more impor-
tant for them than the alleviation of symptoms or the
cure of disease. For people struggling to retain their
social identity, the issue of compliance may not be high
on their agenda. Clinicians who are trying to give their
patients the best evidence about treatment options and
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to present balanced information about risks and benefits
may find it difficult to take this on board.
Clinicians need to engage with patients’ priorities
in order to understand how prescribed drugs will actu-
ally be used once patients have left the consulting
room. Researchers developing interventions to
improve adherence to treatment may not always
engage with patients’ priorities,2 but clinicians have
immediate access to patients’ perspectives. The
integration, within the consultation, of best evidence
and the patients’ priorities is at the heart of
concordance.3
Prescribed drugs may be only one element of an
individual’s strategy of self care. This paper shows that
patients used a range of resources in managing their
chronic ill health. They used a minimum-maximum
strategy—minimal use of drugs and maximal use of
other ways of managing their illnesses. The question
for prescribers is not “How can this person use this
drug most effectively?” but “How does this drug
contribute to this person’s self management and the
attainment of his or her goals?”
1 Horne R, Weinman J, Hankins M. The beliefs about medicines question-
naire: the development and evaluation of a new method for assessing the
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2 Haynes RB, Montague P, Oliver T, McKibbon KA, Brouwers MC, Kanani
R. Interventions for helping patients to follow prescriptions for medica-
tions. Cochrane Database Syst Rev 2000;(2):CD000011.
3 Britten N. Concordance and compliance. In: Jones R, Britten N, Culpep-
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